SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Neurocrine Biosciences Presents Analysis on Meaningful Health Change in Tardive Dyskinesia

The analysis identifies a 6-point increase on the EQ Visual Analogue Scale as a threshold for clinically meaningful change in patients’ reported overall health.

NBIX

Related stories